# Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

> **NCT02149342** · PHASE1,PHASE2 · COMPLETED · sponsor: **Joint Authority for Päijät-Häme Social and Health Care** · enrollment: 14 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** Hexylaminolaevulinate cream
- **DRUG:** Methylaminolaevulinate cream

## Key facts

- **NCT ID:** NCT02149342
- **Lead sponsor:** Joint Authority for Päijät-Häme Social and Health Care
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02149342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02149342, "Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02149342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*